Clinical Trial

A Phase II Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer

Name: A Phase II Trial Evaluating Upfront Stereotactic Body Radiotherapy in Stage III Advanced Non-small Cell Lung Cancer — clinical trial record (NCT07565987)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: APRIL

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of the study is to test the feasibility \& loco-regional control rate by combining high precision SBRT with chemotherapy in stage III NSCLC in tumor/lymph nodes if tumors/lymph node size with ≤ 6cms in size.

Trial Details

NCT Number	NCT07565987
Lead Sponsor	All India Institute of Medical Sciences
Conditions	Non Small Cell Lung Cancer
Enrollment	20 participants
Start Date	2023-02-01
Primary Completion	2025-01-30 (estimated)
Study Completion	2027-01-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-04